Latest brain aneurysms Stories
Wisconsin Governor Scott Walker files resolution marking September as Brain Aneurysm Awareness Month in the state of Wisconsin at the recommendation of Brenda Schmittinger, a local survivor. Hanover, MA (PRWEB) June 13, 2011 On April 15, 2011 the Wisconsin State Legislature passed a resolution declaring September 2011 to be Brain Aneurysm Awareness Month. The resolution is designed to raise awareness of the dangers of brain aneurysms and increase public awareness of the symptoms and...
SILVER SPRING, Md., April 13, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has approved the cPAX Aneurysm Treatment System for surgery on brain aneurysms that are difficult to manage because of their size and shape. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) An aneurysm is a bulge in the wall of a blood vessel, which can rupture as it increases in size, causing hemorrhage or death. Brain aneurysms often produce no symptoms until they grow and press...
PALO ALTO, Calif., Feb. 15, 2011 /PRNewswire/ -- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna(TM) Aneurysm Embolization System (AES) received CE Mark for the treatment of patients with brain aneurysms. The Luna AES is designed to be a single-deployment, easy-to-use system for the treatment of brain aneurysms both pre- and post-rupture. "Brain aneurysm treatment historically...
PALO ALTO, Calif., Jan. 11, 2011 /PRNewswire/ -- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, today announced that the company received U.S. Food and Drug Administration 510(k) clearance for its Acta(TM) Vessel Occlusion System (VOS). The Acta VOS provides physicians with a minimally-invasive alternative to current treatment options for an array of common and potentially serious vascular lesions. The Acta...
PALO ALTO, Calif., Oct. 25 /PRNewswire/ -- Nfocus Neuromedical Inc., an innovative medical device company focused on the next generation treatment for brain aneurysms, today announced the appointment of Eric Milledge to Chairman and CEO effective immediately. Milledge has served as the company's Chairman of the Board since April 2009. Former CEO, Martin Dieck, will assume the role of President and COO. Prior to joining Nfocus' Board, Milledge most recently served as Company Group...
Results from a new study suggest that oral contraceptives and hormone replacement therapy (HRT) may yield additional benefit of protecting against the formation and rupture of brain aneurysms in women. The findings from this first-of-its-kind study by a neurointerventional expert from Rush University Medical Center were presented at the Society of Neurointerventional Surgery (SNIS) 7th annual meeting.According to the lead author of the study, Dr. Michael Chen, neurointerventionalist at Rush,...
Findings Announced at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting CARLSBAD, Calif., July 30 /PRNewswire-USNewswire/ -- Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against the...
A new study shows that people with a common heart defect may also be more likely to have brain aneurysms. The study is published in the May 4, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.Up to two percent of the population is born with the heart defect called a bicuspid aortic valve (BAV). The aortic valve allows blood to flow from the heart to the aorta. It normally has three flaps that open and close to regulate blood flow. In people with a...
The risks associated with treating a recurrent or residual brain aneurysm that was initially treated by endovascular coiling are low, according to a multicenter study led by researchers at the University of Cincinnati (UC) Neuroscience Institute. In the study of 311 patients with coiled aneurysms who underwent retreatment procedures at eight academic health centers, the risk of death or permanent major disability was slightly over one in 100, or 1.28 percent. The study is part of an...
OAK LAWN, Ill., June 20 /PRNewswire-USNewswire/ -- Advocate Christ Medical Center in Oak Lawn, Ill. has become one of only a few institutions in the Chicago area, the only one in the Advocate Health Care system and among about 25 hospitals nationally that are using a glue-like liquid for the successful treatment of brain aneurysms without surgery. In a recent two-and-a-half-hour procedure, Thomas J. Grobelny MD, of the medical center's Neurosciences Institute, led a team in use of the...
